Back

Abscence of high lipoprotein(a) levels is and independent predictor of acute myocardial infarction without coronary lesions

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Risk stratification in acute coronary syndromes (4) Acute Myocardial Ischaemia ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Andrea Kallmeyer

Fundacion Jimenez Diaz University Hospital, Madrid (Spain)

6 More presentations in this session

Presentation thumbnail
The impact of smoking status on platelet reactivity and its association on clinical outcomes in east asian AMI patients with stent implantation
Doctor Z. Song (Busan, KR)
Abstract Slides Video
Presentation thumbnail
Long-term prognostic value of white blood cell count variation during hospital stay in patients with STEMI
Doctor M. Boukhris (Limoges, FR)
Abstract Slides Video
Presentation thumbnail
Predictive value of STEP-HF risk score in patients with ST-segment elevation myocardial infarction (Killip I) treated by primary percutaneous coronary intervention
Professor J. Chen (Wuhan, CN)
Abstract Slides Video
Presentation thumbnail
Poor prognosis of total culprit artery occlusion in patients presenting with NSTEMI
Doctor R. Herman (Aalst, BE)
Abstract Slides Video
Presentation thumbnail
Uncertain meaning of early Q-wave in STEMI. Can we still rely on its relevance?
Doctor K. Pupiales Davila (Mexico City, MX)
Abstract Slides Video

Access the full session

Session thumbnail
Risk stratification in acute coronary syndromes (4)

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
Lipoprotein(a) levels in acute coronary syndrome: analysis of sex, age, and cardiovascular risk factors
thumbnail
Congress Presentation
Lipoprotein(a) levels in acute myocardial infarction patients and their associations with prior events and coronary artery disease severity: a real-world cohort study
thumbnail
Congress Presentation
Comparison of lipoprotein (a) levels in patients with a history of coronary artery disease and in normal subjects

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources